We all share the same objective: Ensuring that patients get the medicines and vaccines they need in a timely way.

The COVID-19 pandemic has tested Europe’s medicine supply chains like never before. It has affected manufacturing, trade and logistics. Matching the supply of medicines to fluctuating demand can be a challenge at the best of times. So, what have we learned?

• What does Europe need in order to avoid shortages?
• How can we ensure collaboration all along the supply chains to overcome supply challenges?
• What constitutes strong supply chains? 
• Does security of supply stem from a broader commitment to innovation and competitiveness?